These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma. Bachmaier R; Aryee DN; Jug G; Kauer M; Kreppel M; Lee KA; Kovar H Oncogene; 2009 Mar; 28(9):1280-4. PubMed ID: 19151750 [TBL] [Abstract][Full Text] [Related]
45. Identification of cell surface markers to differentiate rat endothelial and fibroblast cells using lectin arrays and LC-ESI-MS/MS. Lee JE; Mirza SP; Didier DN; Scalf M; Olivier M; Greene AS; Smith LM Anal Chem; 2008 Nov; 80(21):8269-75. PubMed ID: 18821777 [TBL] [Abstract][Full Text] [Related]
46. The potential for molecular therapeutic targets in Ewing's sarcoma. McAllister NR; Lessnick SL Curr Treat Options Oncol; 2005 Nov; 6(6):461-71. PubMed ID: 16242051 [TBL] [Abstract][Full Text] [Related]
47. Molecular recognition by the EWS transcriptional activation domain. Lee KA Adv Exp Med Biol; 2012; 725():106-25. PubMed ID: 22399321 [TBL] [Abstract][Full Text] [Related]
48. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model. Peng W; Huang X; Yang D Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249 [TBL] [Abstract][Full Text] [Related]
49. Prediction and identification of B cell epitopes derived from EWS/FLI-l fusion protein of Ewing's sarcoma. Liu H; Huang L; Luo J; Chen W; Zhang Z; Liao X; Dai M; Shu Y; Cao K Med Oncol; 2012 Dec; 29(5):3421-30. PubMed ID: 22562156 [TBL] [Abstract][Full Text] [Related]
50. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells. Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513 [TBL] [Abstract][Full Text] [Related]
51. Ewing's sarcoma: analysis of single nucleotide polymorphism in the EWS gene. Silva DS; Sawitzki FR; De Toni EC; Graebin P; Picanco JB; Abujamra AL; de Farias CB; Roesler R; Brunetto AL; Alho CS Gene; 2012 Nov; 509(2):263-6. PubMed ID: 22925827 [TBL] [Abstract][Full Text] [Related]
52. Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein. Takahama K; Kino K; Arai S; Kurokawa R; Oyoshi T FEBS J; 2011 Apr; 278(6):988-98. PubMed ID: 21244633 [TBL] [Abstract][Full Text] [Related]
53. Identification of Ewing's sarcoma gene product as a glycoprotein using a monoclonal antibody that recognizes an immunodeterminant containing O-linked N-acetylglucosamine moiety. Matsuoka Y; Matsuoka Y; Shibata S; Yasuhara N; Yoneda Y Hybrid Hybridomics; 2002 Aug; 21(4):233-6. PubMed ID: 12193275 [TBL] [Abstract][Full Text] [Related]
54. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy. Kovar H Expert Opin Ther Targets; 2014 Nov; 18(11):1315-28. PubMed ID: 25162919 [TBL] [Abstract][Full Text] [Related]